GSK grants zanamivir licenseGSK grants zanamivir licenseGlaxoSmithKline(GSK)has granted its first sub-licence to manufacture and supply zanamivir,the active ingredient in the antiviral influenza treatment Relenza,developed by GSK under licence from Australian firm Biota.The sub-licence is granted to Simcer...
Grants and donations We recognise a responsibility to support activities in our medical community, whether related to medical education where there is patient need and common scientific interest, professional societies’ initiatives, or assisting healthcare organisations and projects that promote other health...
Grants and donations We recognise a responsibility to support activities in our medical community, whether related to medical education where there is patient need and common scientific interest, professional societies’ initiatives, or assisting healthcare organisations and projects that promote other health...
Reports on the creation of research grants for HIV/AIDS drugs by GlaxoSmithKline. Identification of the molecular virology of HIV integration; Support of the pharmaceutical industry in drugs research; Development of inventive treatments for HIV/AIDS....
Grants, funds and donations Charitable partnerships GSK Impact awards US corporate funding US charitable investmentsStandards, policies, integrity and complianceImportant matters Find answers on our views and our practices across a range of issues that are important to GSK, our patients and our stake...
COiMMUNITY grants provide a ground-level boost to vaccine advocacy Together we can reduce barriers to adult vaccination. The competitive spirit – getting diversity into the rotation On the court and off, John Palacios has demonstrated a voracious appetite to win. Read more! The role of ...
WHO grants prequalification to GSK's Mosquirix - the first and only approved malaria vaccine GSK plc (LSE/NYSE: GSK) announced that the World Health Organization (WHO) has awarded prequalification to Mosquirix (also known as RTS,S/AS01), GSK's groundbreaking malaria vac...
[3] Press Release: European Commission grants first approval worldwide of Beyfortus® (nirsevimab) for prevention of RSV disease in infants. Retrieved June 2, 2023 from https://www.sanofi.com/en/media-room/press-releases/2022/2022-11-04-07-00-00-2548492 ...
aI did it my way, Not envy the scenery along the way,It's my life 我做我的以方式,不嫉妒风景,它是我的生活[translate] atravel grants from GSK and Roche 旅行津贴从GSK和Roche[translate]
Such high-value UK government-supported research grants have significant benefits for the partnering businesses, acting to de-risk involvement in new fundamental research activities that have the potential for an appreciably high return. With research projects co-created by the academic and business ...